HomeNewsBusinessMarketsSensex, Nifty rangebound; Mid, Smallcap continue to outperform

Sensex, Nifty rangebound; Mid, Smallcap continue to outperform

The market breadth remained strong as more than two shares advanced for every share declining on the Bombay Stock Exchange.

January 05, 2016 / 14:57 IST
Story continues below Advertisement

Moneycontrol Bureau2:55 pm Market Update: Equity benchmarks continued to be directionless due to lack of global and domestic cues. The Sensex fell 36.57 points to 25586.78 and the Nifty declined 3.90 points to 7787.40.More than two shares advanced for every share declining on the Bombay Stock Exchange.2:40 pm Sugar output: Country's sugar output rose by 6.5 percent to 7.98 million tonnes in the first three months of the 2015-16 season while exports were 3,00,000 tonnes in the same period, industry body ISMA said today.Ex-mill sugar prices have improved in the past fortnight by 1-2 per kg but prices still remained below cost of production during October-November period of this season. As per the latest production data released by Indian Sugar Mills Association (ISMA), the country's overall output has increased to 7.98 million tonnes in the October-December period of this year, up by 6.5 per cent from 7.49 million tonnes in the year-ago period.

2:20 pm UBS' Nifty target: Global financial services major UBS today said it is "overweight" on India but sees limited room for a re-rating and forecast an end-2016 Nifty target of 8,200. "We see limited room for a re-rating and forecast an end-2016 Nifty target of 8,200 based on a 15x one-year forward PE multiple," it said in a research note adding that "our GEM/APAC strategists remain overweight on India. According to the Swiss firm, there were big earning downgrades in 2015 and more are likely this year.

Story continues below Advertisement

"Consensus FY16/FY17/FY18 forecasts of 10 percent/20 percent/18 percent earnings growth still appear optimistic," it said adding that cuts in 2016 may remain significant at around 8 percent.

Also read - Mkt may hit 2015 lows; pharma's bull run over for now: IL&FS